2d
Pharmaceutical Technology on MSNUSPTO allows patents for Remedy’s large hemispheric infarction drugThe US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating ...
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
FDA 510(k) clearance of Caristo's CaRi-Plaqueâ„¢ technology advances AI innovator's U.S. commercialization, as it looks to roll ...
Patients treated with baricitinib 4 mg saw significant regrowth of eyebrows and eyelashes at Week 36 compared to placebo Positive data underscore Lilly's continued expansion across dermatologic ...
Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...
FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...
This study aimed to explore the impact of clinical severity on the efficacy of EVT in such ... These patients had large infarcts (defined as Alberta Stroke Program Early CT Score of 3–5 or ...
Average pre-test score was 52.4% (95% CI 49% to 56% ... educational intervention results in substantial improvements in EMS knowledge of prehospital stroke severity scales and severity-based field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results